Jiangbo Pharmaceuticals, Inc.(fka JGBO)

[sunwin]

You are right with the warrents.

The numbers and the outook for 2011 will be good.
What you write about the outlook is o.k.

My predictions are

- net income Q4 >10 million (about the same as Q4 of FY 2009)


- that makes total net income for FY 2010 approx. 32 million (well above their prediction!)
-Felodipine will add 10-12mill.in 2011.
- Hongrui operational, will add 6-10 million in revenues to FY 2011
- outlook for FY 2011: two new TCM's will be out? (Yuandu Hanbi and Bezoar Yijn), market accepts Felodipine very well, revenues $>115 million, net income $35-45 million
- shareprice will climb from $9 to $ >14 by the end of the year.
Time will tell. Sorry for my very bad english.

Long and strong from germany